Gitelman’s syndrome – a diagnosis to have in mind

Authors

  • Mário Barbosa Serviço de Medicina I Hospital de Santa Maria
  • Eleonora D'Apresentação Serviço de Medicina I Hospital de Santa Maria
  • Menezes Falcão Serviço de Medicina I Hospital de Santa Maria

Keywords:

Gitelman’s syndrome, familial hypokalaemia-hypomagnesaemia, benign variant of Bartter’s syndrome, SLC12A3, thiazide-sensitive NaCl cotransporter, NCCT

Abstract

Gitelman’s syndrome, also referred to as familial hypokalaemia-
-hypomagnesaemia or benign variant of Bartter’s syndrome, is
an inherited renal tubular disorder transmitted with an autosomal
recessive pattern.
Clinically it is characterized by hypokalaemia, metabolic
alkalosis, hypomagnesaemia, hypocalciuria and secondary
hyperaldosteronism.
A mutation in the SLC12A3 gene (Solute Carrier Family 12,
Member 3 gene) encoding the thiazide-sensitive NaCl cotransporter (NCCT), is responsible for this syndrome.
Although a rare disease, the heterozygotes prevalence is about
1%, making it one of the most common hereditary renal tubular
diseases.
Most cases are identified, by chance, during adolescence or
in adulthood.
Weakness, paraesthesias, tetany and lower blood pressure
than in the general population, respond well to supplements of
the lacking salts and to potassium sparing diuretics, granting an
excellent long term prognosis, being our case an example.

Downloads

Download data is not yet available.

References

Coto E, Rodriguez J, Jeck N et al. A new mutation (intron 9 + 1 G>T) in the SLC12A3 gene is linked to Gitelman syndrome in Gypsies. Kidney Int. 2004;65(1):25-29.

Rose BD, Post TW. In Clinical Physiology of Acid-Base and Electrolyte Disorders 5th edition. New York: McGraw-Hill. 2001:565-567.

Mitchell JE, Seim HC, Colon E, Pomeroy C. Medical complications and medical management of bulimia. Ann Intern Med 1987;107:71.

Watanabe S, Uchida S. Bartter´s syndrome and Gitelman´s syndrome: Pathogenesis, pathophysiology, and therapy. Nippon Rinsho 2006;64(2):504-507.

Hansen KW, Mosekilde L. Gitelman syndrome. An overlooked disease with chronic hypomagnesemia and hypokalemia in adults. Ugeskr Laeger 2003;165(11):1123-1127.

Oster JR, Materson BJ, Rogers AI. Laxative abuse syndrome. Am J Gastroenterol 1980; 74:451.

Knoers NV, Levtchenkno EN. Gitelman syndrome. Orphanet J Rare Dis.

;3:22.

Riviera-Munoz E, Chang Q, Bindels RJ, Devuyst O. Gitelman´s syndrome: towards genotype-phenotype correlations? Pediatr Nephrol 2007;22(3):326-332.

Cornelissen EA, Bindels RJ, Hoefsloot LH, Knoers NV. From gene to disease; mutations in the SLC12A3 gene as the cause of Gitelman´s syndrome. Ned Tijdschr Geneeskd 2005;149(24):1330-1333.

Reissinger A, Ludwig M, Utsch B et al. Novel NCCT gene mutations as a

cause of Gitelman´s syndrome and a systematic review of mutant and polymorphic NCCT alleles. Kidney Blood Press Res 2002;25(6):354-362.

Yasujima M, Tsutaya S. Mutational analysis of a thiazide-sensitive Na-Cl cotransporter (SLC12A3) gene in a Japanese population- the Iwaki Health Promotion Project. Rinsho Byori 2009;57(4):391-396.

Shaer AJ. Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes. Am J Med Sci 2001;322(6):316-332.

Bhandari S. The pathophysiological and molecular basis of Bartter´s s and Gitelman´s syndromes. Postgrad Med J 1999;75(885):391-396.

Lin SH, Cheng NL, Hsu YJ, Halperin ML. Intrafamilial phenotype variability in patients with Gitelman syndrome having the same mutations in their thiazide-sensitive sodium/chloride cotransporter. Am J Kidney Dis 2004; 43:304.

Cruz DN, Simon DB, Nelson-Williams C et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 2001; 37:1458.

Ji W, Foo JN, O’Roak BJ et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008; 40:592.

Kurschat C, Heering P, Grabensee B. Gitelman´s syndrome: an important differential diagnosis of hypokalemia. Dtsch Med Wochenschr.

;128(22):1225-1228.

Yeum CH, Kim SW, Ma SK et al. Attenuated renal excretion in response to thiazide diuretics in Gitelman´s syndrome: a case report. J Korean Med Sci 2002;17(4):567-570.

Colussi G, Rombolà G, Brunati C, De Ferrari ME. Abnormal reabsorption of Na+/Cl- by the thiazide-inhibitable transporter of the distal convoluted tubule in Gitelman´s syndrome. Am J Nephrol 1997;17(2):103-111.

Gjata M, Tase M, Gjata A, Gjergji Zh. Gitelman´s syndrome (familial hypokalemia-hypomagnesemia). Hippokratia 2007;11(3):150-153.

Fauci AS, Braunwald E, Kasper DL et al. In Harrison´s Principles of Internal Medicine 17th edition. New York: Mc Graw Hill 2008:1800-1803.

Bettinelli A, Vezzoli G, Colussi G, Bianchetti MG, Sereni F, Casari G. Genotype-phenotype correlations in normotensive patients with primary

renal tubular hypokalemic metabolic alkalosis. J Nephrol 1998;11(2):61-69.

Ariceta G, Rodriguez-Soriano J. Inherited renal tubulopathies associated with metabolic alkalosis: effects on blood pressure. Semin. Nephrol 2006;26(6):422-433.

Cruz DN. Prevalence of symptoms in Gitelman’s syndrome. Kidney Int. 2008

Additional Files

Published

2012-03-30

How to Cite

1.
Barbosa M, D’Apresentação E, Falcão M. Gitelman’s syndrome – a diagnosis to have in mind. RPMI [Internet]. 2012 Mar. 30 [cited 2024 Dec. 18];19(1):23-7. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1130

Issue

Section

Case Reports